OpGen (OPGN)
(Delayed Data from NSDQ)
$0.51 USD
-0.02 (-3.21%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.51 0.00 (-0.95%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Price, Consensus and EPS Surprise
OPGN 0.51 -0.02(-3.21%)
Will OPGN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for OPGN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OPGN
Bright Health Group (BHG) Reports Q2 Loss, Lags Revenue Estimates
Buy 5 Top-Ranked Stocks With Rising P/E in July
OPGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bet on DuPont Analysis to Pick 5 Stocks for Stellar Returns
Go Beyond Bargain Hunting; Buy 5 Stocks With Rising P/E
Go Beyond Bargain Hunting, Buy 5 Stocks With Rising P/E
Other News for OPGN
OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
OpGen receives noncompliance notice from Nasdaq
OpGen receives Nasdaq notice regarding delayed Form 10-K
OpGen Inc Announces David Lazar as New CEO
12 Health Care Stocks Moving In Monday's After-Market Session